PURPOSE OF REVIEW: The inherited peripheral neuropathies are a complex group of disorders caused by mutations in more than 50 genes. Scientifically, these disorders provide extensive information on molecular pathways that cause demyelination, axonal loss, and abnormal interactions between Schwann cells and the axons they ensheathe. Clinically, however, these neuropathies are confusing because it is difficult to determine what gene to test for in a given patient, inheritance patterns may differ among patients, and genetic testing is expensive. This review provides a biological context and guidelines to help neurologists better understand the basis and focus of genetic testing for these disorders. RECENT FINDINGS: In the past 5 years, many of the genetic causes of inherited neuropathies have been discovered and the phenotypes of inherited neuropathies have been characterized. Clinical trials of genetic neuropathies are now underway. SUMMARY: It is hoped that this review will lead to a better understanding of these fascinating neuropathies for health care professionals and that this improved understanding will facilitate treatment advances for these presently untreatable diseases.
PURPOSE OF REVIEW: The inherited peripheral neuropathies are a complex group of disorders caused by mutations in more than 50 genes. Scientifically, these disorders provide extensive information on molecular pathways that cause demyelination, axonal loss, and abnormal interactions between Schwann cells and the axons they ensheathe. Clinically, however, these neuropathies are confusing because it is difficult to determine what gene to test for in a given patient, inheritance patterns may differ among patients, and genetic testing is expensive. This review provides a biological context and guidelines to help neurologists better understand the basis and focus of genetic testing for these disorders. RECENT FINDINGS: In the past 5 years, many of the genetic causes of inherited neuropathies have been discovered and the phenotypes of inherited neuropathies have been characterized. Clinical trials of genetic neuropathies are now underway. SUMMARY: It is hoped that this review will lead to a better understanding of these fascinating neuropathies for health care professionals and that this improved understanding will facilitate treatment advances for these presently untreatable diseases.
Authors: Kelly A Grussendorf; Christopher J Trezza; Alexander T Salem; Hikmat Al-Hashimi; Brendan C Mattingly; Drew E Kampmeyer; Liakot A Khan; David H Hall; Verena Göbel; Brian D Ackley; Matthew Buechner Journal: Genetics Date: 2016-06-22 Impact factor: 4.562
Authors: Leah R Reznikov; Qian Dong; Jeng-Haur Chen; Thomas O Moninger; Jung Min Park; Yuzhou Zhang; Jianyang Du; Michael S Hildebrand; Richard J H Smith; Christoph O Randak; David A Stoltz; Michael J Welsh Journal: Proc Natl Acad Sci U S A Date: 2013-02-04 Impact factor: 11.205
Authors: Alexander Grimm; Maria Rasenack; Ioanna M Athanasopoulou; Nele Maria Dammeier; Christina Lipski; Stefan Wolking; Debora Vittore; Bernhard F Décard; Hubertus Axer Journal: J Neurol Date: 2015-11-11 Impact factor: 4.849
Authors: Ye Ji Choi; Young Se Hyun; Soo Hyun Nam; Heasoo Koo; Young Bin Hong; Ki Wha Chung; Byung-Ok Choi Journal: J Clin Neurol Date: 2014-11-11 Impact factor: 3.077
Authors: Oranee Sanmaneechai; Shawna Feely; Steven S Scherer; David N Herrmann; Joshua Burns; Francesco Muntoni; Jun Li; Carly E Siskind; John W Day; Matilde Laura; Charlotte J Sumner; Thomas E Lloyd; Sindhu Ramchandren; Rosemary R Shy; Tiffany Grider; Chelsea Bacon; Richard S Finkel; Sabrina W Yum; Isabella Moroni; Giuseppe Piscosquito; Davide Pareyson; Mary M Reilly; Michael E Shy Journal: Brain Date: 2015-08-25 Impact factor: 13.501